Plunkett Research Online: Cyteir Therapeutics Inc

CYTEIR THERAPEUTICS INC (CYT) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cyteir Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing the next generation of precision oncology medicines that inhibit DNA damage repair and cause cancer cell death through a therapeutic strategy known as synthetic lethality. Its lead program is .....


CYTEIR THERAPEUTICS INC

Ticker: CYT
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 857 285-4140
Fax:
Address: 128 Spring Street
Lexington, MA 2421 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Markus RenschlerCEO/Director/President
David GaieroCFO/Chief Accounting Officer/Treasurer/Vice President, Divisional
See More
Cyteir Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing the next generation of precision oncology medicines that inhibit DNA damage repair and cause cancer cell death through a therapeutic strategy known as synthetic lethality. Its lead program is .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture